1 Oct 2026, 09:38
Company UpdateMS
NSBNEUROSCIENTIFIC BIOPHARMACEUTICALS LTD
Announcement history available from 1 August 2025
Fromto
8 Sept 2026, 15:59
Meetings & Governance—
8 Sept 2026, 15:33
Meetings & Governance—
4 Sept 2026, 13:55
Other—
25 Aug 2026, 17:55
Company Administration—
25 Aug 2026, 17:52
Financial ResultsMS
13 Aug 2026, 08:22
Company Update—
28 July 2026, 10:02
Quarterly ReportsMS
21 July 2026, 11:08
Presentations—
1 July 2026, 09:56
Securities Administration—
19 June 2026, 13:12
Securities Administration—
11 June 2026, 12:50
Presentations—
9 June 2026, 08:21
Substantial Holders—
3 June 2026, 17:26
Substantial Holders—
2 June 2026, 17:41
Director Interests—
1 June 2026, 17:35
Securities Administration—
1 June 2026, 17:30
Securities Administration—
26 May 2026, 12:17
Presentations—
26 May 2026, 09:30
Company UpdateMS
25 May 2026, 09:44
Trading Halt / SuspensionMS
30 Apr 2026, 08:46
Quarterly ReportsMS
17 Mar 2026, 09:38
Company Update—
25 Feb 2026, 19:00
Financial ResultsMS
16 Feb 2026, 09:53
Presentations—
30 Jan 2026, 08:27
Quarterly ReportsMS
13 Jan 2026, 09:51
Company UpdateMS
9 Jan 2026, 09:27
Trading Halt / SuspensionMS
12 Nov 2025, 15:06
Meetings & Governance—
12 Nov 2025, 10:00
Company Administration—
11 Nov 2025, 09:26
Company UpdateMS
6 Nov 2025, 09:28
Company Administration—
30 Oct 2025, 09:10
Quarterly ReportsMS
21 Oct 2025, 09:23
Presentations—
7 Oct 2025, 09:27
Company Update—
2 Oct 2025, 10:15
Meetings & Governance—
2 Oct 2025, 10:15
Meetings & Governance—
19 Sept 2025, 08:56
Substantial Holders—
16 Sept 2025, 09:46
Meetings & Governance—
16 Sept 2025, 09:28
Securities Administration—
28 Aug 2025, 17:23
Company Administration—
28 Aug 2025, 17:23
Financial ResultsMS
27 Aug 2025, 09:49
Company UpdateMS
19 Aug 2025, 08:47
Presentations—
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 1 Oct 2026, 09:38 | Leading CRO Appointed for Phase 2 Crohn's Trial | Company Update | MS | 11001 | |
| 8 Sept 2026, 15:59 | Notice of Annual General Meeting & Proxy Form | Meetings & Governance | — | 08001, 08004 | |
| 8 Sept 2026, 15:33 | Letter to Shareholders & Proxy Form | Meetings & Governance | — | 08004, 08006, 16002 | |
| 4 Sept 2026, 13:55 | Resignation and Appointment of Auditor | Other | — | 12018 | |
| 25 Aug 2026, 17:55 | Appendix 4G & Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 25 Aug 2026, 17:52 | 2026 Annual Report & Appendix 4E | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 13 Aug 2026, 08:22 | Pre-IND Meeting with US FDA Scheduled | Company Update | — | 11001 | |
| 28 July 2026, 10:02 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 21 July 2026, 11:08 | StemSmart Presentation - ISCT ANZ 2026 | Presentations | — | 03026 | |
| 1 July 2026, 09:56 | Notification of cessation of securities - NSB | Securities Administration | — | 06027 | |
| 19 June 2026, 13:12 | Escrowed Securities Update | Securities Administration | — | 06009 | |
| 11 June 2026, 12:50 | Investor Webinar | Presentations | — | 14014 | |
| 9 June 2026, 08:21 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 3 June 2026, 17:26 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 2 June 2026, 17:41 | Change of Director's Interest Notice x2 | Director Interests | — | 02009 | |
| 1 June 2026, 17:35 | Section 708A Notice | Securities Administration | — | 06018 | |
| 1 June 2026, 17:30 | Application for quotation of securities - NSB | Securities Administration | — | 06020 | |
| 26 May 2026, 12:17 | Updated Presentation - Successful Results | Presentations | — | 03026 | |
| 26 May 2026, 09:30 | Remarkable Results from Patients treated with StemSmart | Company Update | MS | 09014, 11001 | |
| 25 May 2026, 09:44 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 30 Apr 2026, 08:46 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 17 Mar 2026, 09:38 | StemSmart Manufacturing Scale-Up Transfer Advances | Company Update | — | 11001 | |
| 25 Feb 2026, 19:00 | Half Yearly Report and Accounts | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 16 Feb 2026, 09:53 | Company Presentation | Presentations | — | 03026 | |
| 30 Jan 2026, 08:27 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19002, 19007 | |
| 13 Jan 2026, 09:51 | Successful Clinical Results Achieved under Special Access | Company Update | MS | 09014, 11001 | |
| 9 Jan 2026, 09:27 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 12 Nov 2025, 15:06 | Results of Annual General Meeting | Meetings & Governance | — | 08003 | |
| 12 Nov 2025, 10:00 | Investor Webinar Update | Company Administration | — | 12008 | |
| 11 Nov 2025, 09:26 | Fourth Patient Commences StemSmart MSC Treatment | Company Update | MS | 11001 | |
| 6 Nov 2025, 09:28 | Clinical & Scientific Advisory Board Appointed | Company Administration | — | 12008 | |
| 30 Oct 2025, 09:10 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19001, 19006 | |
| 21 Oct 2025, 09:23 | AusBiotech Presentation | Presentations | — | 03026 | |
| 7 Oct 2025, 09:27 | First Patients Approved for Special Access Program | Company Update | — | 11001 | |
| 2 Oct 2025, 10:15 | Letter to Shareholders & Proxy Form | Meetings & Governance | — | 08001, 08004 | |
| 2 Oct 2025, 10:15 | Notice of Meeting & Proxy Form | Meetings & Governance | — | 08001, 08004 | |
| 19 Sept 2025, 08:56 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 16 Sept 2025, 09:46 | Date of AGM & Closing Date for Director Nominations | Meetings & Governance | — | 08006, 12008 | |
| 16 Sept 2025, 09:28 | Notification regarding unquoted securities - NSB | Securities Administration | — | 06021 | |
| 28 Aug 2025, 17:23 | Appendix 4G & Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 28 Aug 2025, 17:23 | 2025 Annual Report & Appendix 4E | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 27 Aug 2025, 09:49 | Previous StemSmart Studies Support Renal Transplantation | Company Update | MS | 11001 | |
| 19 Aug 2025, 08:47 | Presentation - TechKnow Invest Roadshow Conference | Presentations | — | 03026 |
1–43 of 43
1 / 1